Stock listing

NASDAQ:KZIA Kazia Therapeutics Ltd Stock

Follow Kazia Therapeutics Ltd into a list and get an email when it puts out news.

Share price · NASDAQ:KZIA

$4.92 USD -0.57 (-10.4%)

Close on Nov 20, 2026

Past year -34.2% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$4.50 – $5.48 USDNov 20, 2026
Volume
731,926 sharesNov 20, 2026
Market cap
$56.22M USDAt the close on Nov 20, 2026 · price × 11.43M shares outstanding
52-week range
$4.50 – $17.40 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$2.91M USDMedian day 226,313 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Kazia Therapeutics Ltd logo

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:KZIA · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$4.92-0.57-10.4%$5.25$5.48$4.50731,926
$5.49+0.18+3.4%$5.25$5.75$5.25226,313
$5.31-0.29-5.2%$5.61$5.85$5.20650,804
$5.60-1.02-15.4%$6.68$6.69$5.361,408,948
$6.62-0.33-4.7%$6.88$6.995$6.255352,750
$6.95-0.48-6.5%$7.50$7.65$6.81166,345
$7.43+0.03+0.4%$7.51$7.72$7.33154,472
$7.40-0.01-0.1%$7.41$7.812$7.32130,854
$7.41+0.23+3.2%$7.30$7.57$7.25123,539
$7.18+0.18+2.6%$7.01$7.40$6.89155,355
$7.00-1.08-13.4%$7.99$7.99$7.00186,157
$8.080.000.0%$8.27$8.54$7.74238,418
$8.08+0.06+0.7%$8.01$8.226$7.931114,542
$8.02-0.48-5.6%$8.63$8.75$7.804156,039
$8.50-0.22-2.5%$8.71$8.71$7.92230,400
$8.72+0.39+4.7%$9.10$9.10$8.35220,800
$8.33+0.16+2.0%$8.27$8.37$8.06160,800
$8.17+0.30+3.8%$8.03$8.54$7.81231,900
$7.87+0.06+0.8%$8.00$8.18$7.60189,200
$7.81-0.26-3.2%$7.98$8.06$7.4852,700
$8.07-0.11-1.3%$8.04$8.36$7.25128,800
$8.18+0.30+3.8%$8.11$8.38$8.04166,100
$7.88+0.03+0.4%$8.21$8.21$7.81168,200
$7.85+0.60+8.3%$7.42$7.93$7.31245,200
$7.25-0.15-2.0%$7.44$7.79$7.15273,200
$7.40+0.61+9.0%$6.80$7.59$6.80385,700
$6.79-1.25-15.5%$7.85$8.31$6.62825,300
$8.04-0.77-8.7%$8.77$8.94$8.00273,800
$8.81-0.12-1.3%$9.05$9.18$8.7266,800
$8.93+0.11+1.2%$8.89$9.08$8.75123,400
$8.82-0.47-5.1%$9.25$9.51$8.71252,400
$9.29+0.03+0.3%$9.20$9.53$9.14133,500
$9.26-0.09-1.0%$9.53$9.65$9.16129,900
$9.35+0.08+0.9%$9.31$9.54$9.12240,600
$9.27-0.20-2.1%$9.59$9.74$9.12128,700
$9.47-0.13-1.4%$9.56$9.69$9.37132,200
$9.60-0.15-1.5%$9.90$9.90$9.46188,100
$9.75+0.15+1.6%$9.72$9.84$9.43176,400
$9.60+0.03+0.3%$9.44$10.26$9.33285,500
$9.57-0.21-2.1%$9.77$9.99$9.42244,300
$9.78+0.18+1.9%$9.50$9.99$9.01561,000
$9.60-1.32-12.1%$10.95$10.95$9.23526,500
$10.92+0.27+2.5%$10.80$11.25$10.71321,100
$10.65+0.26+2.5%$10.53$10.79$10.19193,500
$10.39-0.47-4.3%$10.89$11.00$10.38169,900
$10.86+0.66+6.5%$10.52$10.90$10.16446,800
$10.20-0.16-1.5%$10.50$10.97$10.15353,800
$10.36-0.80-7.2%$11.11$11.11$10.21495,700
$11.16-0.03-0.3%$11.12$11.64$11.12153,200
$11.19+0.18+1.6%$11.10$11.43$10.83340,700
$11.01-0.87-7.3%$11.75$11.75$10.83374,300
$11.88-0.13-1.1%$12.50$12.75$11.76238,000
$12.01-0.30-2.4%$12.29$12.47$11.95158,700
$12.31+0.15+1.2%$12.00$12.62$11.77414,400
$12.16-0.45-3.6%$12.62$12.99$12.04413,500
$12.61-0.02-0.2%$12.66$13.13$12.05359,100
$12.63-1.14-8.3%$13.69$13.69$12.27612,100
$13.77+0.19+1.4%$13.70$14.42$13.00377,900
$13.58-3.32-19.6%$15.48$15.50$13.301,179,300
$16.90+2.30+15.8%$14.67$17.18$14.67985,900
$14.60+0.81+5.9%$13.79$14.79$13.62100,700
$13.79+0.59+4.5%$13.25$13.98$13.2592,900
$13.20-0.21-1.6%$13.36$13.42$13.0061,800
$13.41-0.26-1.9%$13.67$13.96$13.06149,000
$13.67-0.40-2.8%$13.96$13.97$13.4499,600

Splits

5 splits since 2012 · NASDAQ:KZIA · every price before a split is adjusted for it

DayRatioWhat
1-for-5Consolidation
1-for-10Consolidation
1-for-4Consolidation
161-for-53Split
1-for-5Consolidation
Ticker
NASDAQ:KZIA
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

All Kazia Therapeutics Ltd news

Kazia Therapeutics Ltd on 6ix

Sector
Health care
Industry
Biotechnology
News releases
5 in the last 12 months · 5 in all · newest Nov 19, 2026 · oldest 2026
Decks
64 decks · latest Sep 1, 2026

Valuation

EV/sales 373× against a median of 8.5×: the highest of 7 Biotechnology companies shown. Statements: Year to Jun 30, 2025 · balance Dec 31, 2025 · price Nov 20, 2026

Enterprise value
$10.36M USD
P/E
Loss
EV/sales
373×
EV/EBITDA
Negative EBITDA
Price/book
1.8×
Gross margin
100.0%
Operating margin
Revenue too small
Net margin
Revenue too small
Debt to equity
0.0×
Beta vs S&P 500
2.31

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Kazia Therapeutics Ltd · NASDAQ:KZIAUS$56.22MUS$10.36Mn/a373×n/a1.8×n/a0.0×2.31
HeXun Biosciences Co Ltd · TPEX:6986US$57.20MUS$32.05M16.2×3.4×6.5×1.8×37.7%0.0×n/a
iNtRON Biotechnology, Inc. · KRX:048530US$57.03MUS$31.18Mn/a5.8×n/a1.2×−142.6%0.0×n/a
Tenax Therapeutics, Inc. · NASDAQ:TENXUS$56.92M−US$56.78Mn/an/an/a0.5×n/a0.0×1.35
OKYO Pharma Limited · NASDAQ:OKYOUS$56.15MUS$35.56Mn/an/an/a4.5×n/a0.0×1.02
Gwo Xi Stem Cell Applied Technology Co., Ltd. · TPEX:6704US$55.77MUS$51.65Mn/a9.1×n/a2.5×−43.0%0.3×n/a
Cognition Therapeutics, Inc. · NASDAQ:CGTXUS$55.37MUS$25.10Mn/an/an/a1.9×n/a0.0×2.28
EyeGene, Inc. · KRX:185490US$55.23MUS$26.50Mn/a8.0×n/a1.5×−391.5%0.0×n/a
AB Science SA · EURONEXT:ABUS$55.19MUS$50.54Mn/a39.2×n/an/a−132.6%n/an/a
Azora Therapeutics, Inc. · NASDAQ:AZRUS$55.00MUS$33.00Mn/an/an/an/an/an/a1.00
Island Pharmaceuticals Ltd · ASX:ILAUS$54.84MUS$46.32Mn/a248×n/a6.2×n/a0.0×n/a
Median of the othersUS$55.57MUS$32.53M16.2×8.5×6.5×1.8×−132.6%0.0×1.19

Forecasts

6 strong buy · 3 buy · Analysts' consensus from EODHD, read Nov 9, 2026. Not 6ix's view and not investment advice.

Price target
28.72 USD · Analysts' mean
EPS, year to Jun 2026
-0.011 · 3 analysts
Revenue, year to Jun 2026
1.09M · 6 analysts

Team and board

Officers

OfficerRole
John E. FriendChief Executive Officer
James LevineChief Financial Officer
Elissa HansenCompany Secretary
Jeffrey J. KrawsHead of Corporate Strategy & Development
Sudha RaoChief Scientific Officer

Board

DirectorRole
Robert AppleChairman
Ebru DavidsonNon-Executive Director
Steven CoffeyNon-Executive Director

Events

QuarterResultsShare move
Quarter to Sep 30, 2026Nov 6, 2026+5.9%
Q1 2026Nov 7, 2025−1.5%
Quarter to Mar 31, 2025Jun 10, 2025+80.0%
Q1 2025Nov 15, 2024−3.6%
Q3 2021Jun 30, 2021+1.3%
Q2 2021Mar 31, 2021+3.6%

Open Events

Decks

DeckKindSlidesDate
Corporate Update (September 2026)Corporate update21 slidesSep 1, 2026
Investor Presentation (August 2026)Investor deck39 slidesAug 27, 2026
Investor Presentation (April 2026)Investor deck59 slidesApr 27, 2026
Investor Presentation (April 2026)Investor deck59 slidesApril 2026
Investor Presentation (March 2026)Investor deck55 slidesMar 31, 2026
Shareholder Meeting (March 2026)Shareholder meeting14 slidesMar 26, 2026
Investor Presentation (August 2025)Investor deck40 slidesAugust 2025
Investor Presentation (February 2025)Investor deck43 slidesFeb 3, 2025
Investor Presentation (January 2025)Investor deck43 slidesJanuary 2025
Investor Presentation (November 2024)Investor deck37 slidesNovember 2024
Show 50 decks
DeckKindSlidesDate
Investor Presentation (May 2024)Investor deck18 slidesMay 2024
Investor Presentation (April 2024)Investor deck41 slidesApril 2024
Investor Presentation (March 2024)Investor deck17 slidesMarch 2024
Shareholder Meeting (November 2023)Shareholder meeting10 slidesNov 30, 2023
Corporate Update (June 2023)Corporate update43 slidesJun 26, 2023
Investor Presentation (June 2023)Investor deck39 slidesJun 26, 2023
Shareholder Meeting (November 2022)Shareholder meeting15 slidesNov 16, 2022
HC Wainwright Global Investment Conference 2022Conference18 slidesSep 15, 2022
H.C. Wainwright Global Investment Conference 2022Conference20 slidesSep 14, 2022
Technical Presentation (June 2022)Technical27 slidesJun 23, 2022
Corporate Update (June 2022)Corporate update29 slidesJun 22, 2022
Investor Presentation (January 2022)Investor deck41 slidesJan 19, 2022
Shareholder Meeting (November 2021)Shareholder meeting28 slidesNov 10, 2021
Investor Presentation (August 2021)Investor deck36 slidesAug 16, 2021
Investor Presentation (April 2021)Investor deck34 slidesApr 19, 2021
ShareCafe Micro/Small Cap "Hidden Gems" Webinar (January 2021)Conference14 slidesJan 22, 2021
Bell Potter Healthcare Conference 2020Conference10 slidesNov 26, 2020
Shareholder Meeting (November 2020)Shareholder meeting25 slidesNov 6, 2020
Investor Presentation (October 2020)Investor deck35 slidesOct 1, 2020
HC Wainwright & Co 22nd Annual Investment Conference (September 2020)Conference20 slidesSep 15, 2020
Hidden Gems ShareCafe Investor Webinar (June 2020)Conference18 slidesJun 26, 2020
TechKnow Invest Roadshow Investor Webinar (June 2020)Conference17 slidesJun 16, 2020
Biotech Showcase 2020Conference36 slidesJan 13, 2020
Switzer Small & Microcap Conference 2019Conference17 slidesDec 3, 2019
Shareholder Meeting (November 2019)Shareholder meeting24 slidesNov 13, 2019
Shareholder Meeting (November 2019)Shareholder meeting21 slidesNov 13, 2019
AusBiotech Invest (October 2019)Conference13 slidesOct 31, 2019
Gold Coast Investment Showcase 2019Conference20 slidesJun 25, 2019
Proactive Investors presentation, Sydney and Melbourne, February 2019Conference20 slidesFeb 19, 2019
Proactive Investors presentations, Sydney and Melbourne, February 2019Conference21 slidesFeb 18, 2019
Biotech Showcase 2019Conference26 slidesJan 8, 2019
Biotech Showcase 2019Conference25 slidesJan 7, 2019
Shareholder Meeting (November 2018)Shareholder meeting25 slidesNov 8, 2018
Shareholder Meeting (November 2018)Shareholder meeting22 slidesNov 8, 2018
AusBiotech Invest (October 2018)Conference16 slidesOct 30, 2018
Finance News Network Investor Event (October 2018)Conference18 slidesOct 11, 2018
Finance News Network Investor Event (October 2018)Conference17 slidesOct 11, 2018
Investor Presentation (July 2018)Investor deck35 slidesJul 16, 2018
Gold Coast Investment Showcase 2018Conference20 slidesJun 21, 2018
Proactive Investors CEO Series 2018Conference19 slidesMar 19, 2018

This page holds 50 of 64 decks. Open Decks

Open Decks

Financials

Annual, in AUD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue42.0K2.31M0015.2M988.1K1.56K119.0K249.0K406.0K
Cost of revenue0000
Gross profit42.0K2.31M55510.0K15.2M988.1K1.56K13.1K8.79M4.07M
Research and development7.33M17.4M15.6M20.2M14.5M9.49M6.47M9.77M11.1M9.89M
Selling, general and administrative8.72M13.6M8.58M5.11M7.02M3.69M3.79M5.60M8.53M5.76M
Operating income-14.2M-28.5M-24.1M-25.4M-6.38M-12.2M-8.38M-12.5M-10.9M-12.8M
Depreciation and amortization934.0K1.87M1.87M1.87M1.26M1.08M1.08M1.55M1.42M643.0K
EBITDA-13.3M-26.6M-22.3M-23.5M-5.11M-11.1M-7.30M-10.9M-9.43M-12.1M
Interest expense2.09K5.10M240.0K2.19M01.00K0
Income before tax-22.4M-27.0M-20.7M-25.4M-8.90M-12.8M-10.6M-6.34M-10.9M-12.2M
Income tax-1.75M-271.0K-271.0K-368.0K-484.0K-298.0K-298.0K-305.0K-199.0K2.77M
Net income-20.7M-26.8M-20.5M-25.0M-8.42M-12.5M-10.3M-6.04M-10.7M-12.1M
Earnings per share, basic-0.04-0.10-0.11-0.19-0.07-0.17-17.86-12.48-2.28-2.82
Earnings per share, diluted-0.04-0.10-0.11-0.19-0.07-0.17-17.86-12.48-2.28-2.82

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents4.34M1.66M5.24M7.36M27.6M8.76M5.43M5.96M14.5M33.5M
Short-term investments0000
Receivables97.9K3.90M3.90M91.0K84.0K1.35M1.71M2.54M4.26M91.0K
Inventory-3.79M-84.0K1-1.55M01434.0K
Current assets4.93M6.14M10.8M9.45M29.4M10.7M7.51M9.26M19.5M34.1M
Property, plant and equipment01.00K490.0K592.0K
Goodwill0000
Total assets6.06M21.6M28.1M35.9M58.1M23.1M21.2M28.2M35.9M35.5M
Accounts payable10.1M15.1M4.33M3.76M4.93M3.49M1.76M2.07M1.87M512.0K
Current liabilities14.1M25.8M7.57M6.73M8.33M5.07M1.90M3.89M5.38M1.43M
Long-term debt0000
Total debt396.0K634.0K1.80M1.84M084.0K10.0K10.0K
Total liabilities14.4M31.6M16.0M17.6M20.2M8.94M6.98M8.93M10.6M1.59M
Shareholders' equity-8.30M-10.0M12.1M18.3M37.9M14.1M14.2M19.2M25.3M33.9M
Shares outstanding1.10M479.6K368.6K265.0K235.4K152.5K120.0K101.0K97.6K89.2K

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-13.3M-9.58M-15.2M-22.8M-9.11M-8.81M-6.71M-8.66M-11.4M-12.0M
Capital spending00000000-12.0K-522.0K
Free cash flow-13.3M-9.58M-15.2M-22.8M-9.11M-8.81M-6.71M-8.66M-11.4M-12.5M
Cash from investing00-2.37M-2.36M-2.36M2.36M150.0K-7.12M-522.0K
Cash from financing16.0M5.99M13.0M3.73M28.1M12.1M3.82M3.82M-18.0K782.0K
Dividends paid0000000
Share buybacks3.82M00852.9K
Change in cash2.70M-3.60M-2.18M-21.4M19.0M3.33M-539.0K-8.51M-18.6M-11.7M

Open Financials

Filings

FilingDateTypeFiled with
6-K · Report of a foreign issuerNov 19, 2026Current reportSEC
20-F · Annual reportNov 17, 2026Annual reportSEC
SCHEDULE 13G · Big-stake noticeNov 16, 2026Big-stake noticeSEC
NT 20-FNov 2, 2026Explanation requestSEC
SCHEDULE 13G/A · Big-stake notice, amendedOct 2, 2026Big-stake noticeSEC
424B3 · ProspectusSep 22, 2026Offer documentSEC
424B3 · ProspectusSep 22, 2026Offer documentSEC
424B3 · ProspectusSep 22, 2026Offer documentSEC
424B3 · ProspectusSep 22, 2026Offer documentSEC
6-K · Report of a foreign issuerSep 22, 2026Current reportSEC
Show 200 filings
FilingDateTypeFiled with
424B3 · ProspectusSep 18, 2026Offer documentSEC
424B3 · ProspectusSep 18, 2026Offer documentSEC
424B3 · ProspectusSep 18, 2026Offer documentSEC
424B3 · ProspectusSep 18, 2026Offer documentSEC
6-K · Report of a foreign issuerSep 18, 2026Current reportSEC
424B3 · ProspectusSep 1, 2026Offer documentSEC
424B3 · ProspectusSep 1, 2026Offer documentSEC
424B3 · ProspectusSep 1, 2026Offer documentSEC
424B3 · ProspectusSep 1, 2026Offer documentSEC
6-K · Report of a foreign issuerSep 1, 2026Current reportSEC
424B3 · ProspectusAug 31, 2026Offer documentSEC
424B3 · ProspectusAug 31, 2026Offer documentSEC
424B3 · ProspectusAug 31, 2026Offer documentSEC
424B3 · ProspectusAug 31, 2026Offer documentSEC
6-K · Report of a foreign issuerAug 31, 2026Current reportSEC
6-K · Report of a foreign issuerAug 31, 2026Current reportSEC
424B5 · ProspectusAug 31, 2026Offer documentSEC
6-K · Report of a foreign issuerAug 28, 2026Current reportSEC
424B5 · ProspectusAug 28, 2026Offer documentSEC
424B5 · ProspectusAug 27, 2026Offer documentSEC
424B3 · ProspectusAug 27, 2026Offer documentSEC
424B3 · ProspectusAug 27, 2026Offer documentSEC
424B3 · ProspectusAug 27, 2026Offer documentSEC
424B3 · ProspectusAug 27, 2026Offer documentSEC
6-K · Report of a foreign issuerAug 27, 2026Current reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 19, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 14, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 14, 2026Big-stake noticeSEC
424B3 · ProspectusJul 28, 2026Offer documentSEC
424B3 · ProspectusJul 28, 2026Offer documentSEC
424B3 · ProspectusJul 28, 2026Offer documentSEC
424B3 · ProspectusJul 28, 2026Offer documentSEC
6-K · Report of a foreign issuerJul 28, 2026Current reportSEC
4 · Change in ownershipJul 8, 2026Insider tradeSEC
4 · Change in ownershipJul 8, 2026Insider tradeSEC
4 · Change in ownershipJul 8, 2026Insider tradeSEC
4 · Change in ownershipJul 8, 2026Insider tradeSEC
4 · Change in ownershipJul 8, 2026Insider tradeSEC
4 · Change in ownershipJul 8, 2026Insider tradeSEC
4 · Change in ownershipJun 23, 2026Insider tradeSEC
4 · Change in ownershipJun 23, 2026Insider tradeSEC
3 · Initial statement of ownershipJun 15, 2026Insider tradeSEC
3 · Initial statement of ownershipJun 3, 2026Insider tradeSEC
424B3 · ProspectusJun 2, 2026Offer documentSEC
424B3 · ProspectusJun 2, 2026Offer documentSEC
424B3 · ProspectusJun 2, 2026Offer documentSEC
424B3 · ProspectusJun 2, 2026Offer documentSEC
6-K · Report of a foreign issuerJun 2, 2026Current reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 27, 2026Big-stake noticeSEC
424B3 · ProspectusMay 26, 2026Offer documentSEC
424B3 · ProspectusMay 26, 2026Offer documentSEC
424B3 · ProspectusMay 26, 2026Offer documentSEC
424B3 · ProspectusMay 26, 2026Offer documentSEC
6-K · Report of a foreign issuerMay 26, 2026Current reportSEC
3 · Initial statement of ownershipMay 19, 2026Insider tradeSEC
6-K · Report of a foreign issuerApr 27, 2026Current reportSEC
424B3 · ProspectusApr 15, 2026Offer documentSEC
424B3 · ProspectusApr 15, 2026Offer documentSEC
424B3 · ProspectusApr 15, 2026Offer documentSEC
424B3 · ProspectusApr 15, 2026Offer documentSEC
6-K · Report of a foreign issuerApr 15, 2026Current reportSEC
424B3 · ProspectusApr 13, 2026Offer documentSEC
424B3 · ProspectusApr 13, 2026Offer documentSEC
424B3 · ProspectusApr 13, 2026Offer documentSEC
424B3 · ProspectusApr 13, 2026Offer documentSEC
6-K · Report of a foreign issuerApr 13, 2026Current reportSEC
3/A · Initial statement of ownership, amendedApr 9, 2026Insider tradeSEC
3 · Initial statement of ownershipApr 1, 2026Insider tradeSEC
424B3 · ProspectusMar 31, 2026Offer documentSEC
424B3 · ProspectusMar 31, 2026Offer documentSEC
424B3 · ProspectusMar 31, 2026Offer documentSEC
424B3 · ProspectusMar 31, 2026Offer documentSEC
6-K · Report of a foreign issuerMar 31, 2026Current reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedMar 31, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMar 30, 2026Big-stake noticeSEC
6-K · Report of a foreign issuerMar 30, 2026Current reportSEC
EFFECT · Notice that a registration is effectiveMar 30, 2026Other filingsSEC
CORRESP · Letter to the SECMar 26, 2026Other filingsSEC
UPLOAD · Letter from the SECMar 25, 2026Other filingsSEC
424B3 · ProspectusMar 19, 2026Offer documentSEC
424B3 · ProspectusMar 19, 2026Offer documentSEC
424B3 · ProspectusMar 19, 2026Offer documentSEC
424B3 · ProspectusMar 19, 2026Offer documentSEC
6-K · Report of a foreign issuerMar 19, 2026Current reportSEC
3 · Initial statement of ownershipMar 18, 2026Insider tradeSEC
3 · Initial statement of ownershipMar 18, 2026Insider tradeSEC
3 · Initial statement of ownershipMar 18, 2026Insider tradeSEC
3 · Initial statement of ownershipMar 18, 2026Insider tradeSEC
3 · Initial statement of ownershipMar 18, 2026Insider tradeSEC
F-3 · Registration statementMar 17, 2026Offer documentSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 20, 2026Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeFeb 17, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 12, 2026Big-stake noticeSEC
424B3 · ProspectusJan 27, 2026Offer documentSEC
424B3 · ProspectusJan 27, 2026Offer documentSEC
424B3 · ProspectusJan 27, 2026Offer documentSEC
424B3 · ProspectusJan 27, 2026Offer documentSEC
6-K · Report of a foreign issuerJan 27, 2026Current reportSEC
SCHEDULE 13G · Big-stake noticeJan 23, 2026Big-stake noticeSEC
EFFECT · Notice that a registration is effectiveDec 29, 2025Other filingsSEC
EFFECT · Notice that a registration is effectiveDec 29, 2025Other filingsSEC
424B3 · ProspectusDec 23, 2025Offer documentSEC
424B3 · ProspectusDec 23, 2025Offer documentSEC
424B3 · ProspectusDec 23, 2025Offer documentSEC
424B3 · ProspectusDec 23, 2025Offer documentSEC
EFFECT · Notice that a registration is effectiveDec 23, 2025Other filingsSEC
EFFECT · Notice that a registration is effectiveDec 23, 2025Other filingsSEC
CORRESP · Letter to the SECDec 22, 2025Other filingsSEC
CORRESP · Letter to the SECDec 22, 2025Other filingsSEC
POS AM · Amendment to an effective registrationDec 19, 2025Offer documentSEC
POS AM · Amendment to an effective registrationDec 19, 2025Offer documentSEC
F-1/A · Registration statement, amendedDec 19, 2025Offer documentSEC
F-1 · Registration statementDec 19, 2025Offer documentSEC
6-K · Report of a foreign issuerDec 19, 2025Current reportSEC
DDec 18, 2025Other filingsSEC
6-K · Report of a foreign issuerDec 10, 2025Current reportSEC
6-K · Report of a foreign issuerDec 5, 2025Current reportSEC
6-K · Report of a foreign issuerDec 2, 2025Current reportSEC
424B3 · ProspectusNov 18, 2025Offer documentSEC
424B3 · ProspectusNov 18, 2025Offer documentSEC
424B3 · ProspectusNov 18, 2025Offer documentSEC
6-K · Report of a foreign issuerNov 18, 2025Current reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 14, 2025Big-stake noticeSEC
20-F · Annual reportNov 7, 2025Annual reportSEC
NT 20-FOct 31, 2025Explanation requestSEC
424B3 · ProspectusOct 7, 2025Offer documentSEC
424B3 · ProspectusOct 7, 2025Offer documentSEC
424B3 · ProspectusOct 7, 2025Offer documentSEC
6-K · Report of a foreign issuerOct 7, 2025Current reportSEC
424B3 · ProspectusOct 2, 2025Offer documentSEC
424B3 · ProspectusOct 2, 2025Offer documentSEC
424B3 · ProspectusOct 2, 2025Offer documentSEC
6-K · Report of a foreign issuerOct 2, 2025Current reportSEC
F-1 · Registration statementSep 30, 2025Offer documentSEC
SCHEDULE 13G/A · Big-stake notice, amendedSep 12, 2025Big-stake noticeSEC
424B3 · ProspectusSep 11, 2025Offer documentSEC
424B3 · ProspectusSep 11, 2025Offer documentSEC
424B3 · ProspectusSep 11, 2025Offer documentSEC
6-K · Report of a foreign issuerSep 11, 2025Current reportSEC
DAug 14, 2025Other filingsSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 5, 2025Big-stake noticeSEC
424B3 · ProspectusAug 1, 2025Offer documentSEC
424B3 · ProspectusAug 1, 2025Offer documentSEC
424B3 · ProspectusAug 1, 2025Offer documentSEC
6-K · Report of a foreign issuerAug 1, 2025Current reportSEC
424B3 · ProspectusJul 25, 2025Offer documentSEC
424B3 · ProspectusJul 25, 2025Offer documentSEC
424B3 · ProspectusJul 25, 2025Offer documentSEC
6-K · Report of a foreign issuerJul 25, 2025Current reportSEC
424B5 · ProspectusJul 25, 2025Offer documentSEC
424B3 · ProspectusJul 9, 2025Offer documentSEC
424B3 · ProspectusJul 9, 2025Offer documentSEC
424B3 · ProspectusJul 9, 2025Offer documentSEC
6-K · Report of a foreign issuerJul 9, 2025Current reportSEC
SCHEDULE 13G · Big-stake noticeJun 13, 2025Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeJun 12, 2025Big-stake noticeSEC
424B3 · ProspectusJun 11, 2025Offer documentSEC
424B3 · ProspectusJun 11, 2025Offer documentSEC
424B3 · ProspectusJun 11, 2025Offer documentSEC
6-K · Report of a foreign issuerJun 11, 2025Current reportSEC
424B3 · ProspectusJun 10, 2025Offer documentSEC
424B3 · ProspectusJun 10, 2025Offer documentSEC
424B3 · ProspectusJun 10, 2025Offer documentSEC
6-K · Report of a foreign issuerJun 10, 2025Current reportSEC
424B3 · ProspectusJun 5, 2025Offer documentSEC
424B3 · ProspectusJun 5, 2025Offer documentSEC
424B3 · ProspectusJun 5, 2025Offer documentSEC
6-K · Report of a foreign issuerJun 5, 2025Current reportSEC
424B3 · ProspectusMay 28, 2025Offer documentSEC
424B3 · ProspectusMay 28, 2025Offer documentSEC
424B3 · ProspectusMay 28, 2025Offer documentSEC
6-K · Report of a foreign issuerMay 28, 2025Current reportSEC
424B3 · ProspectusMay 15, 2025Offer documentSEC
424B3 · ProspectusMay 15, 2025Offer documentSEC
424B3 · ProspectusMay 15, 2025Offer documentSEC
6-K · Report of a foreign issuerMay 15, 2025Current reportSEC
424B3 · ProspectusApr 15, 2025Offer documentSEC
424B3 · ProspectusApr 15, 2025Offer documentSEC
424B3 · ProspectusApr 15, 2025Offer documentSEC
6-K · Report of a foreign issuerApr 15, 2025Current reportSEC
424B3 · ProspectusMar 31, 2025Offer documentSEC
424B3 · ProspectusMar 31, 2025Offer documentSEC
424B3 · ProspectusMar 31, 2025Offer documentSEC
6-K · Report of a foreign issuerMar 31, 2025Current reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedMar 19, 2025Big-stake noticeSEC
6-K · Report of a foreign issuerMar 13, 2025Current reportSEC
424B3 · ProspectusFeb 21, 2025Offer documentSEC
424B3 · ProspectusFeb 20, 2025Offer documentSEC
424B3 · ProspectusFeb 20, 2025Offer documentSEC
6-K · Report of a foreign issuerFeb 20, 2025Current reportSEC

This page holds 200 of 1,000 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Kazia Therapeutics Ltd’s releases

Common shares
11,426,899
Fully diluted
11,426,899

Fully diluted

LineShares
Common shares11,426,899

Share count over time

CountShares
Nov 22, 202611,426,899

Open Cap table

Shareholders

Institutions

HolderSharesOf the companyValueAs of
ADAR1 Capital Management, LLC968K0.02%US$9.29MSep 30, 2026
Dauntless Investment Group, LLC866K0.01%US$8.31MSep 30, 2026
Bleichroeder LP490K<0.01%US$4.71MSep 30, 2026
Flputnam Investment Management Co425K<0.01%US$4.08MSep 30, 2026
Stonepine Capital Management, LLC377K<0.01%US$3.62MSep 30, 2026
Boxer Capital Management, LLC372K<0.01%US$3.56MSep 30, 2026
Marshall Wace, LLP358K<0.01%US$3.43MSep 30, 2026
Ameriprise289K<0.01%US$2.77MSep 30, 2026
Ikarian Capital, LLC246K<0.01%US$2.36MSep 30, 2026
Lynx1 Capital Management LP226K<0.01%US$2.17MSep 30, 2026
Show 50 holders
HolderSharesOf the companyValueAs of
Point72 Asset Management, L.P.200K<0.01%US$2.3MSep 30, 2026
Citadel175K<0.01%US$1.68MSep 30, 2026
UBS171K<0.01%US$1.64MSep 30, 2026
Knoll Capital Management, LLC129K<0.01%US$1.24MSep 30, 2026
RBC97,073<0.01%US$931KSep 30, 2026
Ensign Peak Advisors, Inc92,589<0.01%US$888KSep 30, 2026
BNP Paribas84,852<0.01%US$814KSep 30, 2026
Susquehanna77,102<0.01%US$740KSep 30, 2026
J. Goldman & Co LP63,627<0.01%US$611KSep 30, 2026
Barclays60,999<0.01%US$585KSep 30, 2026
SteelPeak Wealth, LLC60,522<0.01%US$581KSep 30, 2026
Westside Investment Management, Inc.56,835<0.01%US$545KSep 30, 2026
Kalehua Capital Management LLC56,013<0.01%US$537KSep 30, 2026
Cooperman Leon G50,000<0.01%US$480KSep 30, 2026
Jane Street45,349<0.01%US$435KSep 30, 2026
Caption Management, LLC43,113<0.01%US$414KSep 30, 2026
PFG Investments, LLC40,000<0.01%US$384KSep 30, 2026
Millennium35,699<0.01%US$343KSep 30, 2026
ACT Capital Partners, L.P.35,000<0.01%US$336KSep 30, 2026
Engineers Gate Manager LP32,362<0.01%US$311KSep 30, 2026
Walleye Capital LLC29,600<0.01%US$284KSep 30, 2026
Raymond James Financial Inc24,199<0.01%US$232KSep 30, 2026
Hrt Financial LP22,569<0.01%US$216KSep 30, 2026
Sequoia Financial Advisors, LLC20,003<0.01%US$192KSep 30, 2026
Morgan Stanley17,690<0.01%US$170KSep 30, 2026
XTX Topco Ltd16,011<0.01%US$154KSep 30, 2026
DAFNA Capital Management LLC15,700<0.01%US$151KSep 30, 2026
Bank of America14,534<0.01%US$139KSep 30, 2026
Citigroup Inc14,063<0.01%US$135KSep 30, 2026
Rockefeller Capital Management L.P.12,700<0.01%US$122KSep 30, 2026
Laird Norton Wetherby Trust Company, LLC11,000<0.01%US$106KSep 30, 2026
Persistent Asset Partners Ltd10,798<0.01%US$104KSep 30, 2026
Stifel Financial Corp10,079<0.01%US$96,708Sep 30, 2026
T3 Companies, LLC10,000<0.01%US$95,950Sep 30, 2026
JPMorgan2,525<0.01%US$24,619Sep 30, 2026
Ascentis Wealth Management, LLC2,409<0.01%US$23,114Sep 30, 2026
FNY Investment Advisers, LLC1,350<0.01%US$12Sep 30, 2026
Rhumbline Advisers1,083<0.01%US$10,387Sep 30, 2026
Tower Research Capital LLC (TRC)934<0.01%US$8,962Sep 30, 2026
Nuveen78<0.01%US$761Sep 30, 2026

This page holds 50 of 54 holders. Open Shareholders

Big stakes

StakeStakeSharesDateFiling
ADAR1 Capital Management, LLC6.20%968KSep 30, 2026Schedule 13G

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
James Levine
Other companies: Cardiff Oncology, Inc. (Chief Financial Officer · Jul 12, 2021 – Mar 11, 2025 · Past); Cidara Therapeutics Inc (Chief Financial Officer · Dec 3, 2018 – Mar 17, 2021 · Past); Verenium Corp (President & CEO, Director · May 1, 2009 – Oct 31, 2013 · Past)
Chief Financial Officer · Since at least Jun 1, 2026
John E Friend II
Other companies: Cellectar Biosciences, Inc. (Chief Medical Officer · Apr 17, 2017 – Mar 4, 2021 · Past)
Chief Executive Officer · Since at least Jan 8, 2026
Robert Apple
Other companies: Antares Pharma Inc (President and CEO, Director · Feb 9, 2006 – May 24, 2022 · Past)
Chairman · Since at least Jan 8, 2026
Ebru DavidsonNon-Executive Director · Since at least Jan 8, 2026
Elissa HansenCompany Secretary · Since at least Nov 5, 2026
Jeffrey BonacordaVP, Finance and Controller · Since at least Jan 8, 2026
Jeffrey J. KrawsHead of Corporate Strategy & Development · Since at least Oct 29, 2026
Jeremy SimpsonProgram Director · Since at least Mar 18, 2026
John E. FriendChief Executive Officer · Since at least Oct 29, 2026
Steven CoffeyNon-Executive Director · Since at least Nov 4, 2026
All 12 people
PersonSeat
Steven R S CoffeyDirector · Since at least Jan 8, 2026
Sudha RaoChief Scientific Officer · Since at least Apr 13, 2026

Open People

Log in to ask 6ix AI your own questions about Kazia Therapeutics Ltd.